New virtual therapy aims to ease anxiety in TNBC survivors

NCT ID NCT07513311

Recruiting now Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether a nurse-led, group-based virtual coping program called RESTORE is feasible and acceptable for people who have finished treatment for triple-negative breast cancer. The program teaches skills like problem-solving, relaxation, and mindfulness to help reduce anxiety and fear of cancer recurrence. Researchers will enroll 75 participants to see if they stick with the program and find it helpful.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RESTORE (nurse-led virtual cognitive-behavioral therapy-based intervention)
What this could lead to: If successful, this program could provide a practical, scalable way to help TNBC survivors manage anxiety and improve their quality of life after treatment.
What could go wrong: This is a small pilot study focused on feasibility, not on proving the program works. It may not show meaningful improvements in distress or quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CANCER (TNBC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TRIPLE-NEGATIVE BREAST CANCER (TNBC)

Contacts and locations

Locations

Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02144, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.